Which neurotransmitter effect occurs with anxiolytic medication?

Choice A rationale Glutamate is the primary excitatory neurotransmitter in the central nervous system. Its facilitation would increase neuronal activity, which is generally contrary to the desired calming and sedative effects of anxiolytic medications, which typically aim to reduce nervous system overactivity to manage anxiety. Choice B rationale Dopamine is a monoamine neurotransmitter involved in reward, motivation, and motor control. While involved in various psychiatric conditions, decreasing excess dopamine is the primary mechanism of action for some antipsychotic medications, not the typical mechanism for anxiolytics, which primarily target anxiety symptoms. Choice C rationale Serotonin, a monoamine, modulates mood, sleep, and appetite. Increasing its release or effects is the primary mechanism for some classes of antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), which are also used for anxiety, but is not the defining or typical mechanism of benzodiazepine anxiolytics. Choice D rationale γ-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain. Anxiolytic drugs, particularly the benzodiazepine class, exert their effect by binding to the GABA_A receptor. This binding enhances GABA's inhibitory effects, leading to hyperpolarization of the neuron, thereby reducing overall neuronal excitability and promoting an anxiolytic (calming) effect.